Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survival
Crossref DOI link: https://doi.org/10.1007/s00280-014-2665-8
Published Online: 2014-12-30
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kasuga, Akiyoshi
Okano, Naohiro
Naruge, Daisuke
Kitamura, Hiroshi
Takasu, Atsuko
Nagashima, Fumio
Furuse, Junji
Text and Data Mining valid from 2014-12-30